This announcement is a separate document:
金河生物：北京市中伦（上海）律师事务所关于金河生物科技股份有限公司2023年限制性股票激励计划回购注销部分限制性股票、调整回购价格及调整公司层面业绩考核指标事宜的法律意见书
Jinhe Biotechnology: Legal Opinion of Beijing Zhonglun (Shanghai) Law Firm on Jinhe Biotechnology Co., Ltd.'s 2023 Restricted Stock Incentive Plan to repurchase and cancel some restricted stocks, adjust repurchase prices, and adjust company-level performance assessment indicators
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.